Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to fall 30.59% to -35 cents per share on July 28

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q2'25

Est.

$-0.35

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.16

Q3'24

Est.

$-0.37

Q2'24

Beat

by $0.05

The last earnings report on May 12 showed earnings per share of -50 cents, missing the estimate of -37 cents. With 335.36K shares outstanding, the current market capitalization sits at 52.72M.

View a ticker or compare two or three

Compare

ATNM